Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (351-360 of 385) with videos related to

Pageof 39
Sort By:
Blood|January 19, 2012
Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AMLZejuan Li, Hao Huang, Yuanyuan Li, et al.
Nature|November 26, 2020
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasmsAshok Kumar Jayavelu, Tina M Schnöder, Florian Perner, et al.
Journal of Hematology & Oncology|August 19, 2024
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patientsAdriane Halik, Marlon Tilgner, Patricia Silva, et al.
Nature|December 8, 2016
A 17-gene stemness score for rapid determination of risk in acute leukaemiaStanley W K Ng, Amanda Mitchell, James A Kennedy, et al.
Leukemia|July 28, 2021
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study resultsFrank G Rücker, Ling Du, Tamara J Luck, et al.
Leukemia|July 4, 2024
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY studyAlberto Hernández-Sánchez, Teresa González, Marta Sobas, et al.
Cancers|September 27, 2025
Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity TherapyKatja Krüger, Razif Gabdoulline, Martin Wichmann, et al.
British Journal of Haematology|May 26, 2025
Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patientsSjoerd J F Hermans, Jurjen Versluis, Erik D van Werkhoven, et al.
Leukemia|February 9, 2026
Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemiaRabea Mecklenbrauck, Angela Villaverde Ramiro, Eric Sträng, et al.
Leukemia|January 14, 2026
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY studyAlberto Hernández-Sánchez, Ángela Villaverde Ramiro, Eric Sträng, et al.
Pageof 39

Showing results (351-360 of 385) with videos related to

Sort By:
Pageof 39
Blood|January 19, 2012
Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AMLZejuan Li, Hao Huang, Yuanyuan Li, et al.
Nature|November 26, 2020
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasmsAshok Kumar Jayavelu, Tina M Schnöder, Florian Perner, et al.
Journal of Hematology & Oncology|August 19, 2024
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patientsAdriane Halik, Marlon Tilgner, Patricia Silva, et al.
Nature|December 8, 2016
A 17-gene stemness score for rapid determination of risk in acute leukaemiaStanley W K Ng, Amanda Mitchell, James A Kennedy, et al.
Leukemia|July 28, 2021
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study resultsFrank G Rücker, Ling Du, Tamara J Luck, et al.
Leukemia|July 4, 2024
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY studyAlberto Hernández-Sánchez, Teresa González, Marta Sobas, et al.
Cancers|September 27, 2025
Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity TherapyKatja Krüger, Razif Gabdoulline, Martin Wichmann, et al.
British Journal of Haematology|May 26, 2025
Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patientsSjoerd J F Hermans, Jurjen Versluis, Erik D van Werkhoven, et al.
Leukemia|February 9, 2026
Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemiaRabea Mecklenbrauck, Angela Villaverde Ramiro, Eric Sträng, et al.
Leukemia|January 14, 2026
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY studyAlberto Hernández-Sánchez, Ángela Villaverde Ramiro, Eric Sträng, et al.
Pageof 39